
News|Articles|November 26, 2012
FDA approves first cell-culture vaccine for seasonal influenza
FDA approved Influenza Virus Vaccine (Flucelvax, Novartis Vaccines, the first cell-culture-derived vaccine, for individuals aged 18 years of age and older
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
2
Real-World Usage of Biologics in Psoriatic Arthritis
3
Medicare beneficiaries are paying more for price-negotiated drugs, survey finds
4
FDA approves $2.7 million gene therapy for rare metabolic disorder
5





















